Effect of siRNA-promoted Silencing of Prion Protein on Doxorubicin-induced Cell Death Machineries in Human Adriamycin-resistant Small Cell Lung Cancer Cell Line H69AR
Authors:
Preprint
- 26 June 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Multidrug resistance is one of major challenges in cancer therapy. Recent data have proposed that among its many cellular functions, prion protein (PrP) is also involved in the acquisition of a multidrug resistance phenotype of cancer cells. In this study, we examined the effect of PrP on doxorubicin-induced cell death in the human adriamycin-resistant small cell lung cancer cell line H69AR. Methods We established an experimental design with a series of groups including knockdown of PrP expression in H69AR cells by siRNA (siRNA group), doxorubicin treatment at IC50 concentration (Doxo IC50 group) and combination of siRNA transfection/doxorubicin IC50 treatment (siRNA/Doxo IC50 group). qRT-PCR and immunocytochemistry analyses were performed for PrP, CD44, Bax and Beclin-1 expressions. Results siRNA transfection and co-delivery of siRNA transfection/doxorubicin treatment decreased the PrP mRNA expression and immunofluorescence signals for PrP. However, doxorubicin treatment at IC50 concentration increased the PrP levels. Besides, the increased expression of CD44, Bax and Beclin-1 proteins was observed in all three groups. Monodansylcadaverine results indicated that the number of autophagic vacuoles was increased in all the experimental conditions. Conclusions Our results suggest that knockdown of PrP in H69AR cells may ameliorate the doxorubicin-induced cell death machineries such as apoptosis and autophagy. In conclusion, the knockdown of PrP may be an attractive strategy for the treatment of drug-resistant cancers to improve the effect of conventional chemotherapeutics.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Prion protein at the crossroads of physiology and diseaseTrends in Neurosciences, 2012
- Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancerJournal of Clinical Investigation, 2009
- The involvement of cellular prion protein in the autophagy pathway in neuronal cellsMolecular and Cellular Neuroscience, 2008
- Physiology of the Prion ProteinPhysiological Reviews, 2008
- Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell DeathCancer Research, 2007
- Apoptosis and autophagy: regulatory connections between two supposedly different processesApoptosis, 2007
- Cellular prion protein promotes invasion and metastasis of gastric cancerThe FASEB Journal, 2006
- Deletion of Cellular Prion Protein Results in Reduced Akt Activation, Enhanced Postischemic Caspase-3 Activation, and Exacerbation of Ischemic Brain InjuryStroke, 2006
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001